Biophytis S.A.

Equities

ALBPS

FR0012816825

Biotechnology & Medical Research

Real-time Euronext Paris 03:22:12 2024-03-01 am EST 5-day change 1st Jan Change
0.0043 EUR +2.38% Intraday chart for Biophytis S.A. +2.38% -15.69%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise Friday, Set to End Week Up 1.5% MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Set to End Week Higher in Friday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Move Higher in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Lower in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Friday Trading But End Week Higher MT
European Equities Traded in the US as American Depositary Receipts Make Modest Gains in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Move Modestly Higher in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Open Trading Week Modestly Higher Monday MT
European Equities Traded as American Depositary Receipts Down Fall MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading MT
Biophytis S.A. Announces the Publication of the Results of its COVA Phase 2-3 Study in eClinicalMedicine, Part of The Lancet CI
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading MT
Biophytis: study results published in The Lancet CF
European Equities Traded in the US as American Depositary Receipts Trend Lower in First Trading Day of 2024 MT
Biophytis: drawdown of a new tranche of ORNANE bonds CF
Biophytis Draws Down Fourth Tranche of Convertible Bonds Under Deal with US-based Investment Fund Atlas MT
Chart Biophytis S.A.
More charts
Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19. The company is located in Paris, France and Cambridge, Massachusetts.
More about the company
  1. Stock
  2. Equities
  3. Stock Biophytis S.A. - Euronext Paris
  4. News Biophytis S.A.
  5. European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW